Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Nurse-Led digital Check-In keep heart failure patients out of the hospital?

NCT ID NCT05447598

Disease control Sponsor: Vestre Viken Hospital Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a nurse-led remote monitoring program can help heart failure patients after they leave the hospital. About 200 patients will use a digital platform or phone to report symptoms and medication adherence for three months. The goal is to see if this reduces hospital readmissions and improves outcomes compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nurse-led remote monitoring program (digital platform and telephone monitoring)
What this could lead to
If successful, this could provide a practical, scalable way to monitor heart failure patients at home, reducing hospital readmissions and improving quality of life.
What could go wrong
This is a relatively small trial (200 patients) and previous remote monitoring studies have shown mixed results. The intervention may not significantly reduce readmissions or may be difficult for some patients to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

Apr 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age\> 18 years * Known HF diagnosis (ICD-10: I50) recorded in hospital medical records * Admitted to hospital within 7 days before screening for acute HF with symptoms of decompensation including dyspnoea in NYHA class ≥ II, pulmonary congestion on chest x-ray and/or other signs like oedema or positive rales on auscultation and elevated NT-proBNP concentrations at screening * Sign informed consent and expected to participate according to ICH / GCP Exclusion Criteria: * Any condition (e.g. psychosis, alcohol abuse, dementia) or situation that may pose a significant risk to the participant, confuse the results or make participation unethical * Not able to understand Norwegian language * Short life expectancy (\<6 months) due to non-cardiac causes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure, acute are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure, acute Nurse's role Remote monitoring

Contacts and locations

Locations

  • Akershus University Hospital

    Lørenskog, Norway

  • Vestfold Hospital Trust

    Tønsberg, Vestfold and Telemark County, 3103, Norway

  • Vestre Viken Trust Drammen hospital

    Drammen, Viken County, 3004, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.